Hodi FS, Sznol M, Kluger HM. et al.
Long-term survival of ipilimumab-naive patients (pts) with advanced melanoma (MEL) treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) in a phase I trial.
Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2014;
Download Bibliographical Data